This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
Alert! This chapter may be affected by an emergency rule:
DE 3.03(4)(4)Perform any procedure that involves the intentional cutting of soft or hard tissue of the mouth by any means.
DE 3.03(5)(5)Administer nitrous oxide inhalation, except as provided in ch. DE 15.
DE 3.03(6)(6)Administer injectable local anesthesia, except as provided in ch. DE 7.
DE 3.03 HistoryHistory: CR 17-068: r. and recr. Register August 2019 No. 764, eff. 9-1-19; correction in (3) made under s. 35.17, Stats., Register August 2019 No. 764; CR 23-066: am. (6) Register July 2024 No. 823, eff. 8-1-24.
DE 3.04DE 3.04Oral systemic premedications and subgingival sustained release chemotherapeutic agents.
DE 3.04(1)(1)“Oral systemic premedications” means antibiotics that are administered orally to patients prior to providing dental or dental hygiene services in order to mitigate against the risk of patients developing a bacterial infection.
DE 3.04(2)(2)“Subgingival sustained release chemotherapeutic agents” means antibiotics that are applied in periodontal pockets to treat periodontal disease.
DE 3.04(2m)(2m)In this section, “supervising dentist” has the meaning given in s. DE 17.01 (6).
DE 3.04(3)(3)A dentist may delegate to a dental hygienist the administration of oral systemic premedications and subgingival sustained release chemotherapeutic agents to patients only if all of the following conditions are met:
DE 3.04(3)(a)(a) The administration is performed pursuant to a treatment plan for the patient approved by a dentist.
DE 3.04(3)(b)(b) A dentist remains on the premises in which the administration is performed and is available to the patient throughout the completion of the appointment.
DE 3.04(4)(4)Pursuant to the requirements under ss. 447.06 (2) (e) and 447.065 (2), Stats., a dental therapist may delegate to a dental hygienist the administration of oral systemic premedications and subgingival sustained release chemotherapeutic agents to patients only if all of the following conditions are met:
DE 3.04(4)(a)(a) The administration is performed pursuant to a treatment plan for the patient approved by a dentist.
DE 3.04(4)(b)(b) A dentist remains on the premises in which the administration is performed and is available to the patient throughout the completion of the appointment.
DE 3.04(4)(c)(c) The dental therapist has the authority to perform the activity personally, pursuant to the requirements under s. 447.06 (3) (bm) 1. and 2., Stats.
DE 3.04(4)(d)(d) The dental therapist remains under the supervision of the supervising dentist for the duration of the procedure. The dental therapist’s level of supervision shall be the level agreed upon for the procedure, as specified in the dental therapist’s collaborative management agreement described in s. DE 17.03 (5).
DE 3.04(4)(e)(e) The supervising dentist has allowed the dental therapist to perform the administration personally within the dental therapist’s collaborative management agreement, pursuant to the requirements under s. 447.06 (3) (d) 1., Stats.
DE 3.04(4)(f)(f) The supervising dentist has expressly allowed the dental therapist to delegate the administration within the dental therapist’s collaborative management agreement, pursuant to the requirements under s. 447.06 (3) (d) 1., Stats.
DE 3.04(5)(5)In sub. (4), the dentist who approves the treatment plan and remains available to the patient may be a different dentist than the supervising dentist for the dental therapist.
DE 3.04(6)(6)The dental therapist, the dental therapist’s supervising dentist, and the dentist who approves the treatment plan shall be responsible for any services, treatments, or procedures delegated and performed under sub. (4).
DE 3.04 HistoryHistory: Cr. Register, September, 2000, No. 537, eff. 10-1-00; CR 17-068: am. (2) Register August 2019 No. 764, eff. 9-1-19; EmR2410: emerg. cr. (2m), (4) to (6), eff. 7-26-24; CR 24-094: cr. (2m), (4) to (6) Register July 2025 No. 835, eff. 8-1-25.
DE 3.05DE 3.05Topical anesthetics.
DE 3.05(1)(1)In this section:
DE 3.05(1)(a)(a) “Subgingival anesthetics” means non-injectable topical anesthetics applied below the gum tissue as a remediable procedure.
DE 3.05(1)(b)(b) “Topical anesthetics” means anesthetics applied to a body surface such as the skin or mucous membrane as a remediable procedure.
DE 3.05(2)(2)Pursuant to s. 447.06 (2) (c), Stats., a dental hygienist may apply subgingival anesthetics and topical anesthetics to a patient without the presence of a dentist, if all of the following conditions are met:
DE 3.05(2)(a)(a) The remediable procedure is performed under a written or oral prescription.
DE 3.05(2)(b)(b) The dentist who made the written or oral prescription has seen the patient at least once during the 12-month period which immediately precedes all of the following:
DE 3.05(2)(b)1.1. The date on which the written or oral prescription was made.
DE 3.05(2)(b)2.2. The date on which the dental hygiene practice or remediable procedure is performed.
DE 3.05(2)(c)(c) The written or oral prescription specifies the practices and procedures that the dental hygienist may perform with the informed consent of the patient, or, if applicable, the patient’s parent or legal guardian.
DE 3.05 HistoryHistory: CR 23-066: cr. Register July 2024 No. 823, eff. 8-1-24.
Loading...
Loading...
Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published.